Serum sphingomyelins and ceramides are early predictors of memory impairment
about
Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomicsRecent advances in the application of metabolomics to Alzheimer's DiseaseExploring Biomarkers for Alzheimer's DiseaseCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationBlood-based biomarkers of microvascular pathology in Alzheimer's disease.Defects in very long chain fatty acid synthesis enhance alpha-synuclein toxicity in a yeast model of Parkinson's disease.Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume lossCerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.Developing novel blood-based biomarkers for Alzheimer's diseaseCholine-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil.Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairmentPlasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.Elevated plasma ceramides in depressionCeramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot studyAlterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.Novel advances in shotgun lipidomics for biology and medicine.HPTLC-MALDI MS for (glyco)sphingolipid multiplexing in tissues and blood: A promising strategy for biomarker discovery and clinical applications.Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's diseasePhospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathologyPeripheral sphingolipids are associated with variation in white matter microstructure in older adults.Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS).Blood metabolite markers of cognitive performance and brain function in aging.Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study.Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease.Biomarkers for Alzheimer's disease: ready for the next step.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.Quantitative metabolic profiling of lipid mediators.Lipidomics of Alzheimer's disease.Lipidomic Profiles in Diabetes and Dementia.The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120.Sphingomyelinase selectively reduces M1 muscarinic receptors in rat hippocampal membranes.Plasma sphingolipids and depressive symptoms in coronary artery disease.
P2860
Q21560953-3B6D7C61-5928-40D9-AB7F-E8C1B05BAA19Q26828606-530EE64E-C5D1-4238-9456-6B5896A581AFQ28079218-BF635A7D-66EA-4737-B0A4-B26E82C4271FQ28087030-95123D74-E319-4B4C-8EC8-AC843D8DB6ECQ33625663-2664EE47-E050-4497-9497-07E8DC592565Q33802862-65F48F41-90D2-4DC3-9AB2-602B6AF1EB9AQ34007818-61610C3F-317F-4722-B690-16FC5C9C0AFDQ34106300-79ECA2F7-14FA-4270-97D9-2C20BACEEDFBQ34223125-49D1C894-01B1-4C19-8C21-60E851F1F71FQ34394080-BBBEF6CD-DF26-4E72-AA8D-6027CD204ED4Q34421898-CFE2EE5B-C893-4B4D-BA19-762B160A7C24Q34718216-41D6A15C-4358-468B-9A5A-49236792789DQ34994293-74F3E4AF-EAC0-4ADA-9260-C6E91F0A9DF6Q35062581-34ADFEC8-12DD-4F8C-87A8-C1A55D9C155AQ35065194-8668EFA1-92EA-4AC1-B8BD-F4AB08CBD1FEQ35086073-5A8CF8A2-BBD9-46F1-B559-B3470438726DQ35555867-3A5203C2-36FF-4FF5-8A33-6D87BE4FFD66Q35878177-D4435381-6847-403C-8E8E-C91E1A7AF8AFQ36012933-6B119D8A-6102-4378-85DF-C10C7075CB57Q36149981-A8F454B4-3A23-4C4E-A446-960373A505B3Q36437878-7F16D343-2CA8-435E-888B-BEE1B598AA68Q36590043-42FCBA51-36E5-46F8-8182-F14C1B5FD951Q36768801-68DE3D94-2EFE-41F0-A1B0-23085ACC88A4Q36855949-A1BCE602-38DB-4465-8DFA-72317991F860Q36973077-1875269D-A8E9-48AC-9A48-6F5D0941B11AQ37049048-AB43F47D-3B35-49C5-83DF-AD046841F4C6Q37057711-292279E8-7A32-4AB6-B4B7-F7215ABCEF0EQ37091714-9A6AF1ED-FA3E-4E0D-8FF0-9FACA34A542DQ37543795-E27E295F-B32B-43D8-AAA4-F7262C30E14DQ37550487-2705E072-07DA-4850-8BF1-D2AC331A5E8DQ37555730-1118BB47-21FF-4722-A63C-C515FAF24187Q38037157-DAF26D06-EA77-48BC-AEE8-D7DCA30493E7Q38051186-3243CA37-4186-4D0B-A5FC-E1D731056CD6Q38119472-B60C78F5-E4DC-4B9F-B6D3-B2B6405E7B0CQ38191024-91B8F315-17BB-4B54-843F-28B0DA36B61DQ39352421-5B8E2AEA-E641-463A-B832-12A4254B750CQ40401973-219C4A94-B9D0-4A39-9457-7A1976842B9BQ42282888-E65F5712-0CA3-41B4-8510-2E06FEDBB844Q43499814-799D0199-0E5E-4BCC-B4B9-89FB726DFC0FQ46248790-7F1EDE0D-FF5E-40F2-B4FB-3558AB720924
P2860
Serum sphingomyelins and ceramides are early predictors of memory impairment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum sphingomyelins and ceramides are early predictors of memory impairment
@en
Serum sphingomyelins and ceramides are early predictors of memory impairment.
@nl
type
label
Serum sphingomyelins and ceramides are early predictors of memory impairment
@en
Serum sphingomyelins and ceramides are early predictors of memory impairment.
@nl
prefLabel
Serum sphingomyelins and ceramides are early predictors of memory impairment
@en
Serum sphingomyelins and ceramides are early predictors of memory impairment.
@nl
P2093
P2860
P1476
Serum sphingomyelins and ceramides are early predictors of memory impairment
@en
P2093
Constantine G Lyketsos
Michelle C Carlson
Michelle M Mielke
Norman J Haughey
Peter V Rabins
Veera Venkata Ratnam Bandaru
P2860
P356
10.1016/J.NEUROBIOLAGING.2008.03.011
P577
2008-05-05T00:00:00Z